Change over period: —
NSE · EPIGRAL
EPIGRAL
-38.3% from the 52-week high · +16.5% above the low
Meghmani Finechem Ltd. engages in the manufacture of chemicals involved in pigments and pesticides. The company is headquartered in Ahmedabad, Gujarat and currently employs 872 full-time employees. The company went IPO on 2021-08-18. The firm is engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The company is also engaged in the Trading of Agrochemical products. The firm manufactures a range of products: caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The Company’s products are used in alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, soaps & detergent, and other industries. The Company’s subsidiaries include Meghmani Advanced Sciences Limited.
The short version. EPIGRAL reported revenue of ₹746 crore for Sep 2026, up 27.1% from a year earlier. Net profit was ₹65 crore (up 27.5% year on year). Return on equity was 14.9% in Mar 2026. Promoter holding was 68.83% in Sep 2026, down 0.11 points over 8 quarters.
1 · The price
How has the stock traded?
EPIGRAL trades 38.3% below its 52-week high and 16.5% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹746 cr.
Sep 2026 net profit of ₹65 cr.
Unchanged from a year earlier.
Revenue compounded at 5.0% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 746 | 705 | 736 | 597 | 587 | 607 | 628 | 645 |
| Net profit | 65 | 100 | 81 | 39 | 51 | 161 | 87 | 104 |
| Net margin % | 8.7 | 14.1 | 11.0 | 6.5 | 8.7 | 26.5 | 13.8 | 16.1 |
| EPS (₹) | 15.09 | 23.12 | 18.76 | 9.07 | 11.87 | 37.25 | 20.14 | 24.02 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 2527 | 2550 | 1929 | 2188 | 1551 |
| Net profit | 332 | 358 | 196 | 353 | 253 |
| Net margin % | 13.1 | 14.0 | 10.2 | 16.1 | 16.3 |
| EPS (₹) | 76.95 | 82.91 | 47.13 | 85.03 | 60.84 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 14.9% in Mar 2026; debt to equity is 0.25.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 14.9 | 18.8 | 15.6 | 33.1 |
| Return on capital % | 14.8 | 22.3 | 18.1 | 33.0 |
| EBITDA margin % | 22.9 | 28.3 | 25.2 | 31.7 |
| Net margin % | 13.1 | 13.9 | 10.1 | 16.1 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 5.0% | — |
| Profit CAGR | -2.1% | — |
4 · The owners
Who holds it, and are they adding?
Down 0.11 pts over 8 quarters.
Down 2.02 pts over 8 quarters.
Up 0.59 pts over 8 quarters.
+2 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 68.94 | 68.95 | 68.83 | 68.83 | 68.83 | 68.83 | 68.83 | 68.83 | -0.11 |
| FII | 3.01 | 3.01 | 3.05 | 2.71 | 2.36 | 1.54 | 1.03 | 0.99 | -2.02 |
| DII | 4.31 | 4.66 | 4.79 | 4.92 | 5.13 | 4.9 | 5.56 | 4.9 | +0.59 |
| Public | 23.72 | 23.35 | 23.31 | 23.52 | 23.66 | 24.7 | 24.55 | 25.26 | +1.54 |
Mutual fund holdings · Oct 2026
7 schemes hold this stock
5 the month before.
- Bandhan Business Cycle Fund0.58% of NAV
- Bandhan Small Cap Fund0.36% of NAV
- HSBC Value Fund0.3% of NAV
- HSBC Multi Cap Fund0.14% of NAV
- Motilal Oswal BSE 1000 Index Fund0.01% of NAV
- ADITYA BIRLA SUN LIFE BSE TOTAL MARKET ETF0.01% of NAV
- ADITYA BIRLA SUN LIFE BSE TOTAL MARKET INDEX FUND0.01% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for EPIGRAL are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about EPIGRAL
What is the EPIGRAL share price?
EPIGRAL (EPIGRAL) last closed at ₹945.10, up 0.08% on the day. Its 52-week range is ₹810.45 to ₹1,531.00.
What is the market cap of EPIGRAL?
EPIGRAL has a market capitalisation of about ₹4,065 crore. Its price-to-earnings ratio is 14.4.
How are EPIGRAL's latest results?
EPIGRAL reported revenue of ₹746 crore for Sep 2026, up 27.1% from a year earlier. Net profit was ₹65 crore (up 27.5% year on year). Return on equity was 14.9% in Mar 2026. Promoter holding was 68.83% in Sep 2026, down 0.11 points over 8 quarters.
Who owns EPIGRAL?
As of Sep 2026, shareholding was: Promoter 68.83%, FII 0.99%, DII 4.9%, Public 25.26%.
How many mutual funds hold EPIGRAL?
7 mutual fund schemes held EPIGRAL in October 2026. That compares with 5 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 01 Jun 2026 · Final Dividend - Rs. 5
- 20 Jun 2025 · Final Dividend - Rs. 3.5
- 07 Feb 2025 · Interim Dividend - Rs. 2.5
- 02 Jul 2024 · Final Dividend - Rs. 5
- 20 Jun 2023 · Final Dividend - Rs. 2.5
- 01 Feb 2023 · Interim Dividend - Rs. 2.5
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.